scispace - formally typeset
Y

Yoshinobu Kiso

Researcher at Tohoku University

Publications -  124
Citations -  4361

Yoshinobu Kiso is an academic researcher from Tohoku University. The author has contributed to research in topics: Sesamin & Arachidonic acid. The author has an hindex of 33, co-authored 124 publications receiving 4082 citations. Previous affiliations of Yoshinobu Kiso include Okayama University.

Papers
More filters
Journal ArticleDOI

Inhibitory Effects of Oolong Tea Polyphenols on Pancreatic Lipase in Vitro

TL;DR: Data suggested that the presence of galloyl moieties within the structure was required for enhancement of pancreatic lipase inhibition, and it was well-known that flavan-3-ols are polymerized by polyphenol oxidase and/or heating in a manufacturing process of oolong tea.
Journal ArticleDOI

Antihepatotoxic principles of Curcuma longa rhizomes.

TL;DR: An extract of the crude drug “ukon”, the rhizomes of CURCUMA LONGA, exhibited intense preventive activity against carbon tetrachloride-induced liver injury in primary cultured rat hepatocytes and curcuminoids were shown to possess significant antihepatotoxic action.
Journal ArticleDOI

Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea.

TL;DR: A HPLC-method is described for qualitative and quantitative analysis of the coumestans, in the extracts of ECLIPTA ALBA and also WEDELIA CALENDULACEA Less.
Journal ArticleDOI

Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation.

TL;DR: The mechanism of antihepatotoxic action of atractylon, a main sesquiterpenic constituent of ATRACTYLODES rhizomes, was studied and accumulated data support that although both CCl 4 and atractyl generate free radicals respectively by rat liver microsomes, free radical from CCl4 conducts lipid peroxidation and produces liver lesion.
Journal ArticleDOI

Novel antioxidative metabolites in rat liver with ingested sesamin.

TL;DR: It is suggested that sesamin is a prodrug and the metabolites containing the catechol moieties in their structures are responsible for the protective effects of sesamina against oxidative damage in the liver.